Skip to main content
Screener/Healthcare/Biotechnology

RYTM — Rhythm Pharmaceuticals, Inc.

NASDAQ
$115.92+3.82 (+3.41%)
Mid CapHealthcareFastest GrowingHigh Beta
$74.50
$122.20
$111.69
$116.13
EPS (TTM)$-3.13
P/E Ratio-28.64
Dividend Yield—
Market Cap$7.26B
Volume468K
Prev Close$112.10
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$60.1M-$56.7M$-0.8388.1%-94.4%
Q4 '25$57.3M-$47.5M$-0.7391.6%-83.0%
Q3 '25$51.3M-$52.9M$-0.8289.3%-103.1%
Q2 '25$48.5M-$46.6M$-0.7588.6%-96.1%
Q1 '25$32.7M-$49.5M$-0.8188.8%-151.4%
Q4 '24$41.8M-$43.3M$-0.7290.9%-103.5%
Q3 '24$33.3M-$43.6M$-0.7188.5%-131.2%
Q2 '24$29.1M-$32.3M$-0.5389.9%-110.9%
Get Your Daily Market Recap